olaparib targets prostate cancer mutations Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer. Phosphate-binder therapy does not reduce mortality ...

April 29, 2010 (Orlando, Florida) — Taking a proton pump inhibitor (PPI) with a phosphate binder might improve phosphorus control in patients on hemodialysis, according to a retrospective study ...

The medication may represent a new treatment option for dialysis patients, researchers concluded. A team led by Rong Wang, MD, of Shandong Provincial Hospital in Shandong, China, analyzed 8 randomized ...

Please provide your email address to receive an email when new articles are posted on . Data released from the Dialysis Outcomes and Practice Patterns Study Program show use of the calcimimetic ...